Genetic testing for certain adrenal and nerve tumors
Part of Bones, joints & muscles, Cancer, Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at genetic (DNA) changes in people with pheochromocytoma or paraganglioma and related conditions. It may help clarify why these conditions happen and how they run in families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with pheochromocytoma and/or paraganglioma
- You have been diagnosed with a condition linked to pheochromocytoma/paraganglioma
- Or a close family member (relative) has been diagnosed with pheochromocytoma/paraganglioma
- Or a close family member has been diagnosed with a condition linked to pheochromocytoma/paraganglioma
- Your diagnosis must be confirmed (not just suspected)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps doctors better understand and diagnose pheochromocytoma and paraganglioma—rare tumors that release stress hormones and cause high blood pressure and other symptoms. Researchers will study your medical history, blood and urine tests, imaging scans, and genetic information to improve how these conditions are found and understood.
This study looks at how the immune system responds to rare adrenal or nerve-related tumors (pheochromocytoma and paraganglioma). Researchers want to understand the tumor's environment, which may help improve future treatments.
This study looks at people who have been newly diagnosed with pheochromocytoma/paraganglioma (PPGL), those with a past history of PPGL, or those with genetic risk for it. It may help doctors better evaluate and understand PPGL using specific tests.
This study aims to find genetic causes of neuroendocrine tumors in Mexican patients. By understanding your DNA, researchers hope to improve diagnosis and treatment for people with these rare conditions.
This study looks at past patient data to find patterns that might predict whether a pheochromocytoma or paraganglioma (rare tumors of the adrenal glands or nerve tissue) will spread. It aims to create a tool to help doctors estimate risk and plan treatment.
This study collects and analyzes molecular (cell/DNA-level) information from endocrine tumors or pre-cancer conditions. It may help doctors better understand these tumors and improve diagnosis and treatment planning when you need surgery or a biopsy.
Hear when a new Pheochromocytoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.